ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 162,24
1,49%
Dow Jones
44 368,56
-0,50%
DAX
22 509,38
1,66%
Brent Oil
74,195
-0,82%
Bitcoin
96 115,39
-1,81%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Schrodinger Inc (SDGR)

  7. Schrodinger Inc (SDGR) Actualités

SDGR

Schrodinger (SDGR)

Schrodinger Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SDGR
DateHeureSourceTitreSymboleSociété
12/02/202522h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SDGRSchrodinger Inc
12/02/202514h30Business WireSchrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26NASDAQ:SDGRSchrodinger Inc
12/02/202500h34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SDGRSchrodinger Inc
22/01/202514h30Business WireSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SDGRSchrodinger Inc
13/01/202513h00Business WireSchrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic PrioritiesNASDAQ:SDGRSchrodinger Inc
20/11/202414h30Business WireSchrödinger to Present at Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
18/11/202414h30Business WireSchrödinger Broadens and Accelerates Predictive Toxicology InitiativeNASDAQ:SDGRSchrodinger Inc
13/11/202422h30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SDGRSchrodinger Inc
12/11/202413h33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SDGRSchrodinger Inc
12/11/202412h50Business WireSchrödinger Reports Third Quarter 2024 Financial ResultsNASDAQ:SDGRSchrodinger Inc
12/11/202412h45Business WireSchrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with NovartisNASDAQ:SDGRSchrodinger Inc
04/11/202414h30Business WireSchrödinger to Present at Jefferies London Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
31/10/202413h30Business WireSchrödinger to Announce Third Quarter 2024 Financial Results on November 12NASDAQ:SDGRSchrodinger Inc
23/10/202412h01Business WireSchrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR SymposiumNASDAQ:SDGRSchrodinger Inc
09/10/202412h06Business WireSchrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR SymposiumNASDAQ:SDGRSchrodinger Inc
19/09/202420h18PR Newswire (US)Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law FirmNASDAQ:SDGRSchrodinger Inc
12/09/202422h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SDGRSchrodinger Inc
14/08/202414h30Business WireSchrödinger to Present at Morgan Stanley Global Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
31/07/202422h21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SDGRSchrodinger Inc
31/07/202422h05Business WireSchrödinger Reports Strong Second Quarter 2024 Financial ResultsNASDAQ:SDGRSchrodinger Inc
26/07/202413h00Business WireSchrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive ToxicologyNASDAQ:SDGRSchrodinger Inc
17/07/202414h58Business WireSchrödinger to Announce Second Quarter 2024 Financial Results on July 31NASDAQ:SDGRSchrodinger Inc
30/05/202422h05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SDGRSchrodinger Inc
22/05/202414h30Business WireSchrödinger to Present at Jefferies Global Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
01/05/202422h00Business WireSchrödinger Reports First Quarter 2024 Financial ResultsNASDAQ:SDGRSchrodinger Inc
10/04/202414h30Business WireSchrödinger to Announce First Quarter 2024 Financial Results on May 1NASDAQ:SDGRSchrodinger Inc
20/03/202415h27Business WireSchrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National MeetingNASDAQ:SDGRSchrodinger Inc
28/02/202422h05Business WireSchrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:SDGRSchrodinger Inc
20/02/202414h30Business WireSchrödinger to Participate in Upcoming Investor ConferencesNASDAQ:SDGRSchrodinger Inc
14/02/202414h30Business WireSchrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28NASDAQ:SDGRSchrodinger Inc
 Showing the most relevant articles for your search:NASDAQ:SDGR

Dernières Valeurs Consultées

BIT
1UBER
Uber Technologies
LSE
FCU
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces